Zheng Li
221004, PR China
Puerto Rico
Puerto Rico
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 55 publications
Design, synthesis, and biological evaluation of novel HuR inhibitors.
Journal: Biochemical and biophysical research communications
Published: June 28, 2026
Akkermansia muciniphila-derived L-norleucine modulates FABP1-dependent fatty acid transport.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: May 28, 2026
Discovery of the first-in-class highly potent FXR/HSD17B13 dual modulator for the treatment of metabolic dysfunction-associated steatohepatitis.
Journal: Bioorganic chemistry
Published: January 24, 2026
Case Report: Multi-sensory integration treatment for preschool children with intermittent exotropia and idiopathic scoliosis comorbidity.
Journal: Frontiers in medicine
Published: October 30, 2025
Effect of Chang'an decoction on ulcerative colitis by regulating T helper 17 cells and regulatory T cellsRab27 in the p53/high mobility group box 1 pathway.
Journal: Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan
Published: September 28, 2025
Electroacupuncture Combined With Paroxetine Improves Depression-Like Behavior in Rats by Regulating SIRT2/AMPAR in the Hippocampal Dentate Gyrus.
Journal: Journal of integrative neuroscience
Published: July 10, 2025
Discovery of P11-2: A Potent First-in-Class MNK1-Targeting PROTAC Degrader for the Treatment of Cancer.
Journal: Journal of medicinal chemistry
Published: May 07, 2025
The Multitarget Compound ZLY032 Achieves Treatment of Chronic Wounds.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: February 18, 2025
Structure optimization of natural product piperine to obtain novel and potent analogs with anti-inflammation pain and urate-lowering effect.
Journal: European journal of medicinal chemistry
Published: February 14, 2025
Discovery of the first-in-class FABP/PPAR multiple modulator for the treatment of metabolic dysfunction-associated steatohepatitis.
Journal: European journal of medicinal chemistry
Published: February 11, 2025
Discovery of First-in-Class FXR and HSD17B13 Dual Modulator for the Treatment of Metabolic Dysfunction-Associated Fatty Liver Disease.
Journal: Journal of medicinal chemistry
Published: January 24, 2025
Last Updated: 09/26/2026